FDA approves AstraZeneca's non-small cell lung cancer treatment

FDA approves AstraZeneca's non-small cell lung cancer treatment

Source: 
Reuters
snippet: 

The U.S. Food and Drug Administration approved AstraZeneca's (AZN.L) blockbuster cancer drug, Imfinzi, for the treatment of patients with a type of non-small cell lung cancer on Thursday.